OptimizeRX (OPRX) PT Lowered to $17 at Stifel After Flattish Q4 Revenue Mar 6, 2026 07:25AM
OptimizeRX (OPRX) PT Lowered to $10 at Stephens Mar 6, 2026 06:54AM
Optimizerx Corporation (OPRX) Tops Q4 EPS by 29c Mar 5, 2026 04:11PM
OptimizeRx expands point-of-care network through four new partnerships Dec 17, 2025 04:41AM
Optimizerx Corporation (OPRX) Tops Q3 EPS by 16c Nov 6, 2025 04:46PM


Oct 10, 2025 04:18AM Citizens Raises OptimizeRX (OPRX) PT to $23 on Subscription Growth, Margin Potential
Aug 19, 2025 07:30AM OptimizeRx names new executives in leadership restructuring
Aug 11, 2025 04:08AM OptimizeRX (OPRX) PT Raised to $20 at Citizens JMP
Aug 7, 2025 04:06PM Optimizerx Corporation (OPRX) Tops Q2 EPS by 22c
Jun 24, 2025 07:32AM Optimizerx Corporation (OPRX) Appoints CEO Steve Silvestro to its Board
Jun 20, 2025 10:19AM Simulmedia and OptimizeRx (OPRX) partner to enable self-serve availability of MNT audiences
Jun 9, 2025 07:31AM OptimizeRX (OPRX) PT Raised to $16 at Stifel
May 13, 2025 09:10AM OptimizeRX (OPRX) PT Raised to $14 at Citizens JMP
May 13, 2025 07:22AM Optimizerx Corporation (OPRX) Tops Q1 EPS by 20c ; Offers Guidance
Mar 28, 2025 04:35PM Optimizerx Corporation (OPRX) Files $75M Mixed Shelf
Mar 11, 2025 07:30AM Optimizerx Corporation (OPRX) Confirms Receipt of Notice of Director Nominations
Mar 10, 2025 07:30AM Optimizerx Corporation (OPRX) Appoints Stephen Silvestro as CEO
Jan 8, 2025 12:46AM RBC Capital Downgrades OptimizeRX (OPRX) to Sector Perform
Dec 24, 2024 08:47AM Lake Street Capital Markets Reiterates Buy Rating on OptimizeRX (OPRX)
Dec 24, 2024 07:55AM Stifel Reiterates Buy Rating on OptimizeRX (OPRX) Amid CEO Departure
Dec 23, 2024 10:58PM OptimizeRX (OPRX) PT Lowered to $13 at B.Riley
Dec 23, 2024 08:45AM Optimizerx Corporation (OPRX) Announces CEO Change
Nov 14, 2024 08:50AM OptimizeRX (OPRX) PT Lowered to $11 at Lake Street Capital Markets
Nov 13, 2024 05:24PM Optimizerx Corporation (OPRX) Tops Q3 EPS by 6c
Sep 10, 2024 07:30AM Optimizerx Corporation (OPRX) Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
Aug 16, 2024 06:25AM OptimizeRX (OPRX) PT Lowered to $14 at RBC Capital
Jul 23, 2024 07:31AM Optimizerx Corporation (OPRX) Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation